NEW YORK (GenomeWeb News) – Genetic diagnostics firm Invitae today announced it completed a Series E financing round that raised $40 million.

The funds will go toward further development of the San Francisco-based company's clinical genetic tests for hereditary disorders, including oncology, cardiology, neurology, and pediatric medicine, it said, adding that it plans to expand into international markets.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: Icelandic genome sequences, approach to increase CRISPR efficiency, and more.

Testing showing "genetic incompatibilities" have led thousands of couples in Saudi Arabia to call off their weddings, the BBC reports.

Decode Genetics' ability to tell Icelanders, even ones the company hasn't sequenced, about their disease risk brings up ethical questions.

Genetic analysis of Britain's King Richard III and modern descendants of his relatives indicate breaks in the male line.